U.S. markets close in 2 hours 43 minutes
  • S&P 500

    +14.09 (+0.41%)
  • Dow 30

    +123.24 (+0.44%)
  • Nasdaq

    +10.15 (+0.09%)
  • Russell 2000

    +16.63 (+1.04%)
  • Crude Oil

    +0.61 (+1.52%)
  • Gold

    -27.20 (-1.41%)
  • Silver

    -0.57 (-2.24%)

    -0.0038 (-0.32%)
  • 10-Yr Bond

    +0.0300 (+3.68%)

    -0.0046 (-0.35%)

    +0.2400 (+0.23%)

    +2,010.16 (+18.18%)
  • CMC Crypto 200

    +7.44 (+2.91%)
  • FTSE 100

    +9.15 (+0.16%)
  • Nikkei 225

    -165.19 (-0.70%)

FDAnews Announces -- Patents & FDA Regulation of Pharmaceutical Products Webinar Oct. 22, 2020

·2 mins read

What are the best ways to use patents and FDA exclusivity to protect product? This webinar has the answers.

FALLS CHURCH, Va., Oct. 8, 2020 /PRNewswire-PRWeb/ -- Patents & FDA Regulation of Pharmaceutical Products
An FDAnews Webinar
Wednesday, Oct. 22, 2020, 1:30 p.m.-3:00 p.m. EDT

Patents and intellectual property (IP) might be the key to success for the drugs a company is developing. How does one talk to one's patent attorneys and IP specialists about relevant regulatory and compliance mandates? Has the team considered the importance of exclusivity? Are you moving down one of the two major pathways to enable generic and biosimilar drug development?

Through the Patents & FDA Regulation of Pharmaceutical Products webinar on Oct. 22, attendees will get a broad look at how patents and IP relate to drug development and discover how these processes work to provide market exclusivity, keeping competitors at bay.

Patent attorney Joanna Brougher will share different strategies companies can use to develop strong patent portfolios. She'll also explore how to supplement those patent strategies with FDA exclusivities to protect against competitors.

During this webinar, we'll cover:

  • How patents and the FDA regulatory process overlap, including during the drug approval process

  • The differences between patent exclusivity and FDA exclusivity, including compliance

  • The various types of FDA exclusivity available and what that means to regulatory specialists

  • Strategies for using exclusivity to build a strong patent portfolio and protect against competitors

  • Reasons drugs manufacturers should understand strategic patent processes

  • Potential weaknesses in patents and how FDA exclusivity can help maintain market protection

  • How orphan drug and pediatric exclusivity can encourage drug development

A strong patent portfolio and a deep understanding of FDA exclusivity can protect drug development from competitors and provide a path toward market success for a product. Ensure the team understands these processes with this essential webinar on patents and IP issues.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

Webinar Details:
Patents & FDA Regulation of Pharmaceutical Products
An FDAnews Webinar
Wednesday, Oct. 22, 2020, 1:30 p.m.-3:00 p.m. EDT

$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/pharmapatents
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations